Mr. Conrad has been a director of Celldex since March 2004. He was President of Roche Pharmaceuticals in the United States from 1982 until his retirement in 1993. Mr. Conrad currently serves on the board of Matinas BioPharma Holdings and as an advisor to the Seaver Autism Center at Mount Sinai Hospital. He previously served as Chairman of Matinas, Pharmasset, GenVec and Bone Care International, and he served as a director of Arbutus Biopharmaceuticals and Reliant Pharmaceuticals, where he was a co-founder. Mr. Conrad received B.S. and M.S. degrees from the Brooklyn College of Pharmacy and an honorary doctorate in humane letters from Long Island University.